by Medicine by Design | May 2, 2025
CCRM, the publisher of Signals, has enhanced its long-standing relationship with the University of Toronto’s Medicine by Design through a new strategic alliance. This portrait is one in a series of portraits that feature “people of Medicine by Design.” Some minor...
by Tara Fernandez | Jul 7, 2021
In early 2021, a young boy in Barcelona was the first to receive Pfizer’s investigational gene therapy for Duchenne muscular dystrophy (DMD). This was part of a global Phase 3 human trial to test Pfizer’s lead candidate, PF-06939926, in a cohort of 99 patients with...
by Stacey Johnson | Feb 19, 2016
I had the pleasure of talking about my career to my daughter’s class when she was in grade 5. In an effort to keep the kids awake, I avoided a potentially sleep-inducing talk about corporate communications and instead focused most of my presentation on giving a simple...
Comments